Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters

Database
Language
Document Type
Year range
1.
Med Hypotheses ; 143: 110066, 2020 Oct.
Article in English | MEDLINE | ID: covidwho-625121

ABSTRACT

The COVID-19 pandemic has not spared any continent. The disease has affected more than 7,500,000 individuals globally and killed approximately 450,000 individuals. The disease is caused by a very small virus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is an enveloped single-stranded RNA virus with a spike-like structure on its envelope that can interact with the angiotensin-converting enzyme 2 (ACE2) receptor after cleavage. ACE2 receptors are present in the human lungs and other organs. SARS-CoV-2 is a new virus that belongs to the subgenus Sarbecovirus; viruses in this subgenus have spread widely in the previous years and caused outbreaks of severe acute respiratory syndromes.


Subject(s)
Betacoronavirus/immunology , Coronavirus Infections/immunology , Models, Immunological , Pneumonia, Viral/immunology , Ageusia/etiology , Angiotensin-Converting Enzyme 2 , Betacoronavirus/pathogenicity , COVID-19 , Coronavirus Infections/complications , Coronavirus Infections/drug therapy , Coronavirus Infections/virology , Expectorants/therapeutic use , Host Microbial Interactions/immunology , Humans , Hypersensitivity/immunology , Hypersensitivity/virology , Mucus/metabolism , Olfaction Disorders/etiology , Pandemics , Peptidyl-Dipeptidase A/metabolism , Pneumonia, Viral/complications , Pneumonia, Viral/virology , Respiratory Mucosa/immunology , Respiratory Mucosa/metabolism , Respiratory Mucosa/virology , SARS-CoV-2 , SOXB1 Transcription Factors/metabolism , COVID-19 Drug Treatment
SELECTION OF CITATIONS
SEARCH DETAIL